| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5602e08f73fe5adbfb0cb6cb17c2258
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_886e921e557396ac0dd521ce1ceada90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a1f854df4456e89239ba086c5bf8526
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6df982791f5193c37ee196aeff441900
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_17c6c7da627b7bead7208250127b52c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0dcf9ba337cbf5405cdd86846f10e58c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-5421
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-5412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-368 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-532
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54306
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543 |
| filingDate |
2012-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9c9562da4d3509b646f67ac3de39815
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49fd0ac5f2381e56c14fd0db78f8a385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73f1d6034ec224304ee971f7b6c27ce7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_689fee5b8f0e81047aea5a32f83604d9 |
| publicationDate |
2014-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2014212899-A1 |
| titleOfInvention |
Method for noninvasive prediction or diagnosis of inflammation and infection in amniotic fluid of patients with premature rupture of membranes |
| abstract |
Provided is a method for noninvasive prediction or diagnosis of inflammation and/or infection in amniotic fluid leaked through the cervix into the vagina to predict the concentration of inflammatory markers in the amniotic fluid inside uterus by measuring the concentration of inflammatory markers (various cytokines). Further provided is a method for prediction or diagnosis of inflammation and/or infection in amniotic fluid by measuring the concentration of markers (IL-6, IL-1β IL-8, MCP-1, GRO-α) in the amniotic fluid leaked through the cervix into the vagina in patients with premature rupture of membranes. The method can be performed more stably on pregnant women, as compared to the conventional method for prediction or diagnosis of inflammation and/or infection using invasively collected amniotic fluid. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102022118-B1 |
| priorityDate |
2011-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |